Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
5.69
-0.11 (-1.90%)
At close: Oct 03, 2025, 3:59 PM
5.78
1.58%
After-hours: Oct 03, 2025, 05:54 PM EDT
Cellectar Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.52 | -0.55 | -1.46 | -1.44 | -24.84 | -1.08 | -1.71 | -0.43 | -0.54 | -0.56 | -0.32 | -0.66 | -0.08 | -1.72 | -1.7 | -2.39 | -2.6 | -3.05 |
PEG Ratio | 0.02 | -0.00 | 0.02 | -0.00 | 0.26 | -0.01 | 0.02 | -0.01 | -0.01 | 0.01 | -0.07 | 0.01 | -0.00 | -0.46 | 4.87 | 0.16 | 0.19 | -0.05 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.53 | 1.76 | 0.96 | 5.55 | 6.64 | 8.29 | -3.9 | 6.54 | -47.02 | 2.20 | 1.67 | 1.61 | 0.12 | 1.55 | 1.22 | 1.44 | 1.43 | 1.56 |
P/FCF Ratio | -2.24 | -1.55 | -1.26 | -9.18 | -6.45 | -8.6 | -5.45 | -3.45 | -2.92 | -2.24 | -2.11 | -2.92 | -0.42 | -8.32 | -8.69 | -8.65 | -9.12 | -16.31 |
P/OCF Ratio | -2.24 | -1.55 | -1.26 | -9.18 | -6.46 | -8.61 | -5.61 | -3.7 | -2.92 | -2.24 | -2.15 | -2.93 | -0.42 | -8.37 | -8.94 | -8.66 | -9.13 | -16.31 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.06 | 0.06 | 0.03 | 0.03 | 0.04 | 0.04 | -0.04 | 0.12 | -1.25 | 0.08 | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 2.15 | 2.47 | 2.58 | 1.77 | 1.84 | 1.45 | 0.41 | 1.22 | 0.87 | 1.99 | 1.78 | 2.88 | 4.51 | 6.75 | 9.16 | 13.07 | 13.39 | 10.84 |
Current Ratio | 2.15 | 2.47 | 2.58 | 1.77 | 1.84 | 1.45 | 0.41 | 1.22 | 0.87 | 1.99 | 1.78 | 2.88 | 4.51 | 6.75 | 9.16 | 13.07 | 13.39 | 10.84 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.73 | -0.8 | -0.16 | -0.97 | -0.07 | -1.92 | 0.57 | -3.84 | 21.80 | -0.98 | -1.3 | -0.61 | -0.37 | -0.23 | -0.18 | -0.15 | -0.14 | -0.13 |
Return on Assets | -0.4 | -0.41 | -0.09 | -0.39 | -0.03 | -0.62 | -0.65 | -0.81 | -1.56 | -0.48 | -0.57 | -0.4 | -0.29 | -0.19 | -0.16 | -0.14 | -0.13 | -0.12 |
Return on Invested Capital | -0.76 | -0.63 | -0.81 | -0.78 | -0.96 | -0.83 | 0.94 | -1.83 | -70.59 | -1.1 | -0.73 | -0.6 | -0.36 | -0.22 | -0.18 | -0.15 | -0.14 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |